Is Centogene Stock a Good Investment?

Centogene Investment Advice

CNTG

To provide specific investment advice or recommendations on Centogene B V stock, we recommend investors consider the following general factors when evaluating Centogene B V. This will help you to make an informed decision on whether to include Centogene in one of your diversified portfolios:

Examine Centogene's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Centogene's leadership team and their track record. Good management can help Centogene navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Health Care Providers & Services space and any emerging trends that could impact Centogene's business and its evolving consumer preferences.
Compare Centogene's performance and market position to its competitors. Analyze how Centogene is positioned in terms of product offerings, innovation, and market share.
Check if Centogene pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Centogene's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Centogene B V stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Centogene B V is a good investment.

Sell

Buy

Strong Sell

We provide trade advice to complement the prevailing expert consensus on Centogene B V. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Centogene is not overpriced, please confirm all Centogene B V fundamentals, including its price to earning, cash per share, target price, as well as the relationship between the gross profit and book value per share . As Centogene B V appears to be a penny stock we also recommend to validate its number of shares shorted numbers.

Market Performance	Modest	Details
Volatility	Out of control	Details
Hype Condition	Over hyped	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Quite High	Details
Economic Sensitivity	Very regressive towards the market	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Not Available	Details
Financial Strenth (F Score)	Healthy	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Possible Manipulator	Details

Examine Centogene Stock

Researching Centogene's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 67.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.86. Some equities with similar Price to Book (P/B) outperform the market in the long run. Centogene B V recorded a loss per share of 1.39. The entity had not issued any dividends in recent years.

To determine if Centogene is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Centogene's research are outlined below:

	Centogene B V is way too risky over 90 days horizon
	Centogene B V has some characteristics of a very speculative penny stock
	Centogene B V appears to be risky and price may revert if volatility continues
	Centogene B V has high likelihood to experience some financial distress in the next 2 years
	The company reported the previous year's revenue of 48.54 M. Net Loss for the year was (35.53 M) with profit before overhead, payroll, taxes, and interest of 17.7 M.
	Centogene B V currently holds about 42.67 M in cash with (31.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
	Roughly 67.0% of the company shares are held by institutions such as insurance companies

Centogene uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Centogene B V. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Centogene's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	21st of May 2024 Upcoming Quarterly Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	21st of May 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Centogene's market capitalization trends

The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.43 M.

Centogene's profitablity analysis

The company has Profit Margin (PM) of (0.73) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.63) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.63.

Determining Centogene's profitability involves analyzing its financial statements and using various financial metrics to determine if Centogene is a good buy. For example, gross profit margin measures Centogene's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Centogene's profitability and make more informed investment decisions.

Basic technical analysis of Centogene Stock

As of the 21st of March, Centogene shows the Mean Deviation of 4.48, downside deviation of 15.73, and Risk Adjusted Performance of 0.08. Centogene B V technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Centogene B V jensen alpha, as well as the relationship between the potential upside and skewness to decide if Centogene B V is priced correctly, providing market reflects its regular price of 0.14 per share. As Centogene B V appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Centogene's Outstanding Corporate Bonds

Centogene issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Centogene B V uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Centogene bonds can be classified according to their maturity, which is the date when Centogene B V has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Dana 575 percent Corp Bond US235822AB96	View
	MPLX LP 4125 Corp Bond US55336VAK61	View
	MPLX LP 4875 Corp Bond US55336VAJ98	View
	MPLX LP 52 Corp Bond US55336VAL45	View
	BNP Paribas FRN Corp Bond USF1R15XK367	View
	Morgan Stanley 3591 Corp Bond US61744YAK47	View
	Morgan Stanley 3971 Corp Bond US61744YAL20	View
	MGM Resorts International Corp Bond US552953CD18	View

View All Centogene Corporate Bonds

Understand Centogene's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Centogene's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.08
	Market Risk Adjusted Performance	3.38
	Mean Deviation	4.48
	Semi Deviation	6.15
	Downside Deviation	15.73
	Coefficient Of Variation	1246.63
	Standard Deviation	7.65
	Variance	58.53
	Information Ratio	0.0884
	Jensen Alpha	0.6167
	Total Risk Alpha	1.23
	Sortino Ratio	0.043
	Treynor Ratio	3.37
	Maximum Drawdown	44.96
	Value At Risk	(17.65)
	Potential Upside	13.33
	Downside Variance	247.45
	Semi Variance	37.86
	Expected Short fall	(10.21)
	Skewness	(0.53)
	Kurtosis	2.65

	Risk Adjusted Performance	0.08
	Market Risk Adjusted Performance	3.38
	Mean Deviation	4.48
	Semi Deviation	6.15
	Downside Deviation	15.73
	Coefficient Of Variation	1246.63
	Standard Deviation	7.65
	Variance	58.53
	Information Ratio	0.0884
	Jensen Alpha	0.6167
	Total Risk Alpha	1.23
	Sortino Ratio	0.043
	Treynor Ratio	3.37
	Maximum Drawdown	44.96
	Value At Risk	(17.65)
	Potential Upside	13.33
	Downside Variance	247.45
	Semi Variance	37.86
	Expected Short fall	(10.21)
	Skewness	(0.53)
	Kurtosis	2.65

Consider Centogene's intraday indicators

Centogene intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Centogene stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Daily Balance Of Power	(9,223,372,036,855)
	Rate Of Daily Change	0.82
	Day Median Price	0.14
	Day Typical Price	0.14
	Price Action Indicator	(0.01)
	Period Momentum Indicator	(0.03)
	Relative Strength Index	54.89

Centogene time-series forecasting models is one of many Centogene's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Centogene's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Centogene Stock media impact

Far too much social signal, news, headlines, and media speculation about Centogene that are available to investors today. That information is available publicly through Centogene media outlets and privately through word of mouth or via Centogene internal channels. However, regardless of the origin, that massive amount of Centogene data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Centogene news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Centogene relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Centogene's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Centogene alpha.

Centogene Corporate Management

Ian Rentsch	Chief Pharma	Profile
Peter MD	Chief Officer	Profile
Andrin MD	Advisor	Profile
Kim Stratton	CEO Board	Profile
Bettina Goerner	Chief Officer	Profile
Lennart Streibel	Director Projects	Profile
Florian Vogel	Chief Officer	Profile

When determining whether Centogene B V is a strong investment it is important to analyze Centogene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Centogene's future performance. For an informed investment choice regarding Centogene Stock, refer to the following important reports: